ING Groep NV Grows Stock Holdings in Teleflex Incorporated (NYSE:TFX)

ING Groep NV grew its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 39.0% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 20,201 shares of the medical technology company’s stock after purchasing an additional 5,663 shares during the quarter. ING Groep NV’s holdings in Teleflex were worth $4,996,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Vanguard Group Inc. boosted its stake in Teleflex by 1.8% in the 1st quarter. Vanguard Group Inc. now owns 5,550,727 shares of the medical technology company’s stock worth $1,255,408,000 after buying an additional 96,711 shares during the last quarter. Janus Henderson Group PLC grew its holdings in Teleflex by 12.0% in the first quarter. Janus Henderson Group PLC now owns 5,409,317 shares of the medical technology company’s stock valued at $1,223,424,000 after purchasing an additional 581,312 shares during the period. Cooke & Bieler LP increased its position in Teleflex by 23.3% during the second quarter. Cooke & Bieler LP now owns 912,797 shares of the medical technology company’s stock worth $191,989,000 after purchasing an additional 172,335 shares during the last quarter. TD Asset Management Inc raised its stake in Teleflex by 12.0% during the second quarter. TD Asset Management Inc now owns 456,081 shares of the medical technology company’s stock worth $95,928,000 after purchasing an additional 48,832 shares during the period. Finally, Bank of New York Mellon Corp boosted its holdings in shares of Teleflex by 6.6% in the 2nd quarter. Bank of New York Mellon Corp now owns 425,647 shares of the medical technology company’s stock valued at $89,526,000 after purchasing an additional 26,325 shares during the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on the company. Stephens increased their target price on Teleflex from $275.00 to $290.00 and gave the stock an “overweight” rating in a research report on Friday, August 2nd. Mizuho reduced their price objective on Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a research note on Friday, November 1st. StockNews.com raised shares of Teleflex from a “hold” rating to a “buy” rating in a research report on Tuesday. Truist Financial reaffirmed a “hold” rating and set a $227.00 price target (down from $255.00) on shares of Teleflex in a research report on Monday, November 4th. Finally, Royal Bank of Canada decreased their price objective on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. Three investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat, Teleflex presently has an average rating of “Moderate Buy” and an average price target of $259.25.

Teleflex Trading Up 0.9 %

NYSE TFX opened at $192.15 on Friday. The stock has a market cap of $8.92 billion, a P/E ratio of 38.20, a PEG ratio of 1.99 and a beta of 1.18. The company’s fifty day simple moving average is $231.39 and its 200-day simple moving average is $223.30. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a 52 week low of $189.95 and a 52 week high of $257.85.

Teleflex (NYSE:TFX) last issued its quarterly earnings data on Thursday, October 31st. The medical technology company reported $3.49 EPS for the quarter, topping analysts’ consensus estimates of $3.38 by $0.11. The firm had revenue of $764.40 million for the quarter, compared to analyst estimates of $768.68 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The firm’s revenue was up 2.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $3.64 EPS. Equities research analysts predict that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Friday, November 15th will be paid a dividend of $0.34 per share. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.36 dividend on an annualized basis and a yield of 0.71%. Teleflex’s dividend payout ratio (DPR) is presently 27.04%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.